NCT03297775 Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease Status RECRUITING Phase N/A
NCT03261037 A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period Status COMPLETED Phase NA
NCT03221257 Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Status COMPLETED Phase PHASE2
NCT03215927 Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease Status COMPLETED Phase PHASE2
NCT03099525 Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) Status UNKNOWN Phase N/A
NCT03040674 An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease Status COMPLETED Phase N/A
NCT03018756 Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea Status COMPLETED Phase PHASE3
NCT02958917 Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity Pneumonitis Status TERMINATED Phase PHASE2
NCT02896205 Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease Status COMPLETED Phase PHASE3
NCT02858791 MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT02827734 Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD) Status UNKNOWN Phase N/A
NCT02826265 Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease Status UNKNOWN Phase N/A